4//SEC Filing
Kanesa-thasan Niranjan 4
Accession 0001209191-23-010910
CIK 0001786255other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:10 PM ET
Size
5.4 KB
Accession
0001209191-23-010910
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Kanesa-thasan Niranjan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-15+110,000→ 110,000 totalExercise: $9.06Exp: 2033-02-14→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on February 15, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Icosavax, Inc.
CIK 0001786255
Entity typeother
Related Parties
1- filerCIK 0001874021
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 7:10 PM ET
- Size
- 5.4 KB